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ABSTRACT
Recent studies suggest that PARP1 inhibitors,
several of which are currently in clinical trial, may
selectively kill BRCA1/2 mutant cancers cells. It is
thought that the success of this therapy is based on
immitigable lethal DNA damage in the cancer cells
resultant from the concurrent loss or inhibition of
two DNA damage repair pathways: single-strand
break (SSB) repair and homologous recombination
repair (HRR). Presumably, inhibition of PARP1
activity obstructs the repair of SSBs and during
DNA replication, these lesions cause replication
fork collapse and are transformed into substrates
for HRR. In fact, several previous studies have
indicated a hyper-recombinogenic phenotype in
the absence of active PARP1 in vitro or in
response to DNA damaging agents. In this study,
we demonstrate an increased frequency of spontan-
eous HRR in vivo in the absence of PARP1 using
the p
un assay. Furthermore, we found that the HRR
events that occur in Parp1 nullizygous mice are
associated with a significant increase in large,
clonal events, as opposed to the usually more
frequent single cell events, suggesting an effect in
replicating cells. In conclusion, our data demon-
strates that PARP1 inhibits spontaneous HRR
events, and supports the model of DNA replication
transformation of SSBs into HRR substrates.
INTRODUCTION
Poly (ADP-ribosyl)ation is the posttranslational transfer
of long chains of negatively charged ADP-ribose moieties
to proteins. The resultant increase in negative charge
causes the target protein to lose DNA-binding afﬁnity
(1). Poly (ADP-ribose) polymerases, or PARPs,
comprise a large family of genes that have shared
homology with the catalytic domain of the founding
member, PARP1 (1). PARP1 has been widely implicated
in a multitude of cellular processes including replication
(2–4), transcription [reviewed in (5)], chromatin remodel-
ing [reviewed in (5)], telomere maintenance (6) and
perhaps most notably, the repair of DNA damage
through the base excision repair (BER) pathway (7–9).
Current understanding is that the key BER proteins
actually participate in several distinct pathways such as
short-patch BER, long-patch BER, single strand break
(SSB) repair and nucleotide incision repair (10).
However, the common factor for all of these pathways is
an SSB—be it the initiating lesion or an intermediate step
in a repair process. PARP1 readily binds SSBs (11,12) and
recruits the scaffolding protein XRCC1 (13). PARP1 poly
(ADP-ribosyl)ates itself (13), reducing its DNA-binding
afﬁnity, thus allowing other repair factors to bind the
lesion site (9,14).
A recent study demonstrated that chemical inhibition of
PARP1 decreased the efﬁciency of SSB repair (15),
conjecturing that chemically inhibited PARP1 remains
bound to DNA and blocks other repair proteins from
the SSB site. However, the same study revealed that
despite PARP1 silencing via RNA interference, cells
were able to repair SSBs (15), indicating that an alterna-
tive pathway, possibly homologous recombination repair
(HRR), can compensate for this loss. Loss of Parp1 by
way of gene targeting in human cells does not hinder for-
mation of nuclear RAD51 foci (an indicator of
RAD51-dependent HRR) (16), nor does PARP1 inhib-
ition appear to obstruct HRR in vitro (16,17). Waldman
and Waldman (18) found a 4-fold increase in
intrachromosomal homologous recombination in mouse
ﬁbroblasts grown in the poly(ADP-ribose) polymerase in-
hibitor, 3-methoxybenzamide, compared to controls.
Furthermore, PARP1 does not co-localize to RAD51
foci following DNA damage (16) indicating that it is
unlikely that PARP1 is directly involved in the HRR
process. In addition, increased sister chromatid exchange
has been observed with PARP1 inhibitors in Chinese
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whereas over-expression of Parp1 decreases the incidence
of sister chromatid exchange following DNA damage (21).
Resolution of SSBs by way of HRR in the absence of
PARP1 activity may be due either to stalled replication
fork or DSBs resulting from replication fork collapse. The
requirement of such activity is the postulated basis for
synthetic lethality observed when treating breast and
ovarian cancer cells deﬁcient for either BRCA1 or
BRCA2 with PARP1 inhibitors (4,22–24). This is
because BRCA1 and BRCA2, amongst their various func-
tions, are required for RAD51 dependent double-stranded
DNA break induced HRR (25–27). Together, these
in vitro observations indicate that loss or inhibition of
PARP1 leads to a hyper-recombinogenic phenotype.
Here, we evaluate the spontaneous frequency of HRR
in vivo using the well-established and highly sensitive p
un
eye spot assay (28–30). The murine pink-eyed dilution
gene, p, encodes a protein that functions in the pigmenta-
tion of the fur and the retinal pigment epithelium (RPE) of
the mouse (31). Mice lacking a functional copy of this
gene are hypopigmented, having a dilute (gray) coat and
pink eyes (the cells of the RPE are rendered transparent)
(31). One such mutant, the ‘pink-eyed unstable’ (p
un) al-
lele contains a 70-kb duplication of exons 6–18 (32–34,
Figure 1) and causes this autosomal recessive phenotype.
However, the p
un allele is subject to a relatively high fre-
quency of spontaneous, somatic reversion to wild-type
(35). Reversion can only be attributed to HRR mediated
deletion of the duplicated exons, which restores function-
ality of p (32,33) and consequently pigmentation to the fur
and RPE. Equivalent assays in yeast have demonstrated
that such intrachromosomal deletions between homolo-
gous tandem repeats may be mediated by either a
RAD51-dependent pathway (canonical HRR pathway)
or a RAD51-independent pathway [single strand anneal-
ing (SSA), an alternative HRR pathway)] (36). Therefore,
the frequency of p
un reversion is indicative of the somatic
occurrence of spontaneous HRR events (28,29,37). Here
we use the p
un eye spot assay to demonstrate that the
absence of PARP1 results in increased spontaneous
somatic HRR events in vivo. The signiﬁcant increase in
rare multi-cell clones of eye spots in Parp1 nullizygous
mice suggests that the normal function of PARP1 is to
remove DNA lesions prior to their becoming HRR sub-
strates during DNA replication. Our observations sub-
stantiate current models of the relationship between
PARP1 and HRR, providing formal in vivo evidence of
a spontaneous, hyper-recombination phenotype.
MATERIALS AND METHODS
Generation of mice
Mice heterozygous for a targeted null allele of Parp1,
129S-Parp1tm1Zqw (38), were obtained from Jackson
Laboratories (Bar Harbor, ME) and genotyped for
Parp1 as described (http://parplink.u-strasbg.fr/protocols
/tools/parp1_typing.html) earlier. The Parp1
+/ mice were
made C57BL/6J congenic by ﬁve backcrosses followed
by two crosses to C57BL/6J p
un/un mice. Mice with
homozygous p
un/un genotype were selected by their pheno-
typic gray coat color. The resulting C57BL/6J N7
Parp1
+/ p
un/un mice (hereafter referred to as Parp1
+/)
were self-crossed to create the necessary experimental
(Parp1






un frequency assay was performed as described
earlier (29). Brieﬂy, eyes were harvested, with the investi-
gator blinded to the genotypes until after p
un eye spot data
was collected. Three types of data were collected for each
RPE: the total number of eye spots, the number of cells
comprising each eye spot, and the position of each eye
spot relative to the optic nerve. Following Bishop et al.
(29), a p
un reversion event or eye spot was deﬁned as ‘a
pigmented cell or a cluster of pigmented cells, separated by
no more than one unpigmented cell’. Eyes were viewed at
15 using a Zeiss Axiovert microscope and methodically
scanned for pigmented spots. A 5 mosaic photograph
was taken of each RPE using a Zeiss Lumar V.12 stereo-
microscope, Zeiss Axiovision MRm camera and Zeiss
Axiovision 4.6 software (Thornwood, NY, USA). In
cases where a suspected clone consisted of pigmented
cells separated by clear cell(s), the Adobe Photoshop
CS2 (San Jose, CA, USA) measure tool was used to
assess if the unpigmented area between pigmented cells
was consistent with the single cell diameter in that part
of the RPE (Figure 1). The p
un positional assay was then
performed as described earlier (28). Brieﬂy, the position of
each spot relative to the optic nerve was calculated using
simple measurements. In Photoshop, the brush tool was
used to mark the approximate center of the optic nerve
and the measure tool was then used to obtain two dis-
tances for each eye spot: (i) from the center of the optic
nerve to the proximal edge of the eye spot, and (ii) from
the center of the optic nerve to the edge of the RPE. By
dividing the former by the latter, the position of each eye
spot relative to the optic nerve was determined.
Primary mouse embryonic ﬁbroblasts and cell culture
Primary mouse embryonic ﬁbroblasts (MEFs) were
obtained by intercrossing Parp1 heterozygous mice to
obtain Parp1 null embryos and littermate controls.
Pregnancies were timed by the observation of a vaginal
copulation plug and embryos were harvested on Day
E14. Embryos were mechanically homogenized and
allowed to incubate in 0.05% Trypsin–EDTA for
20min. Cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10000U/ml penicillin,
10000mg/ml streptomycin, 25mg/ml Amphotericin B
(Cellgro). The cells were grown at 37C in the presence
of 5% CO2 in a humidiﬁed incubator.
RAD51 nuclear foci immunoﬂuorescence
HRR frequency was determined by immunoﬂuorescence
using an antibody against RAD51 (RK-70-005, MBL) as
described earlier (39). Cells were grown on acid-washed
ﬁbronectin coated cover slips at a density of 110
5
cells/cover slip. Cells were then ﬁxed with 4%
paraformaldehyde and permeabilized using Triton X-100
Nucleic Acids Research, 2010,Vol.38, No. 21 7539for 10min at room temperature. Blocking was performed
with 1% BSA–4% goat serum for 1h followed by an over-
night incubation with RAD51 antibody (1:2000) in a
humidiﬁed chamber. Goat antichicken Alexa Fluor 488
(Invitrogen) diluted 1:1000 was applied to each cover
slip for 1h followed by DAPI staining and Fluoromount
G slide mounting. A minimum of 100 nuclei were
examined for each genotype, repeated with three technical
replicates per genotype.
Statistics
Parametric analysis of variance was performed in
Microsoft Excel 1994 for Mac (Redmond, Washington).
The Fmax test was done by hand per Hartley (40) and
Rohlf and Sokal (41). Measurements of skew and
kurtosis were obtained using descriptive statistics in
Microsoft Excel 1994 for Mac (Redmond, Washington).
Non-parametric Kruskal–Wallis test was performed using
Stata (College Station, TX, USA). Dunn’s test was done
by hand per Siegel (42). Chi-squared contingency analysis
was performed using the VasserStats online calculator
(http://faculty.vasser.edu/lowry/VasserStats.html,
accessed 11/2009). Fisher’s Exact test (43) was used to
compare RAD51 foci quantiﬁcation using the sum of
the technical replicates per genotype.
RESULTS
Loss of Parp1 leads to a signiﬁcant increase in
HRR in vivo
PARP1, amongst its various activities, is involved in SSB
repair (11,12). Inhibition of the PARP1 protein in BRCA1
and BRCA2 mutant cells leads to their selective cell death
(23,44). This has led to the working model that the
observed cell death is due to immitigable DNA damage
caused by the loss of two key DNA repair pathways: (i)
HRR, due to loss of BRCA1/2, and (ii) SSB repair due to
inhibition of PARP1 (4,23,24). This model suggests that
lack of PARP1 alone will cause an increase in HRR fre-
quency in the absence of exogenous damage. To test this
assumption, we determined the spontaneous frequency of
Figure 1. HR-mediated reversion of the p
un allele. (A) Schematic of the p
un mutation. HR events mediate the deletion of one copy of a tandem repeat
(of Exons 6–18) rendering the p gene functional, thus causing pigmentation of RPE cells. Circles represent centromeres and arrows telomere DNA.
(B) Mosaic image of a Parp1
/ RPE wholemount. The 13 p
un reversion spots are indicated with black arrowheads. (C) Example of two distinct p
un
reversion events within a cluster of pigmented cells. x is the diameter of one cell in this region of the RPE and 2 is twice this diameter. For example,
the two clusters of cells labeled i, are separated by a distance of x and are scored as one event. The cluster labeled ii is a distance of 2 from cluster i,
and therefore represents a distinct event.
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+/ and
+/+ animals using the in vivo p
un
assay.
The frequency of p




+/+ animals using p
un eye spot assay
(Table 1 and Figure 2). There is a clear increase in the
frequency of p
un reversion events observed in the absence
of PARP1 compared to wild-type and heterozygous
littermate controls. Considering that the data is
non-parametric and not normal, we used the
non-parametric Kruskal–Wallis test (followed by Dunn’s
test to determine which groups are different from one
another). This analysis revealed that Parp1
/ animals
had a highly statistically signiﬁcant increase in p
un rever-
sion, and thus increased HRR, compared to controls
(P=0.0001).
Parp1 null mice have an earlier incidence of p
un reversion
than controls
The RPE develops radially outward from the optic nerve
during development (45), therefore, much like the concen-
tric annual rings of a tree, the positions of eye spots
indicate the developmental time at which they occurred
(28,29). p
un reversion events closer to the optic nerve
occurred earlier in development and events further from
the optic nerve occurred later in development (29). To
investigate whether the increased number of events
occurred at a particular time during development, we
analyzed the relative positions of the p
un reversion events
on the RPE of differing Parp1 genotype (35 wild-type, 28
heterozygous and 24 Parp1 null RPE). A Kruskal–Wallis
test was used to compare the positional distribution of
spots and indicated that there is a signiﬁcant difference
between genotypes (P=0.0043, Figure 3). Subsequently,
a Dunn’s test indicated that the Parp1 null group is dif-
ferent from the control groups.
To determine whether the difference in the positions of
spots was due to early or late events, comparison was done
between the numbers of events with proximal positions
(earlier in development, 0–0.50) versus the numbers of
events with distal positions (later in development, 0.51–
1.0). A 23 contingency table analysis comparing
wild-type, heterozygous and null revealed a highly statis-
tically signiﬁcant difference in the proportion of spots on
the proximal half of the RPE ( 
2=32.09, P<0.0001). To
verify that the difference was due to the null group, groups
were analyzed pairwise. There was no signiﬁcant differ-
ence between wild-type and heterozygous (P=0.865),
whereas the null group was signiﬁcantly different from
each of them (P=0.005 and P=0.004, respectively).
Finally, 22 analysis was performed comparing the null
group against the combined heterozygotes and wild-type,
conﬁrming a highly statistically signiﬁcant difference
( 
2=17.86, P<0.0001), indicating that there is a shift
of p
un reversion events to earlier in development. One in-
terpretation of this result is that there is an increased rate
of homologous recombination that occurs in the absence
of PARP1.
Clonal expansion of p
un reversion events is associated with
PARP1 absence
On initial analysis of the RPE, there appeared be a greater
number of large (consisting of multiple cells) spots in the
Parp1
/ RPE (Table 1). Previous studies have shown
that spots with greater than 10 cells are very rare (28,30,
Bishop, unpublished data). Therefore, a 23 contingency
table analysis (Chi-square) was computed comparing the
number of spots with 10 or fewer cells and the number of
spots with 11 or more cells between genotypes ( 
2=32.65,
P<0.0001, Figure 4). To determine if the null group is
Figure 2. The frequency of p
un reversion events in the RPE (pigmented
eye spots) in mice with differing Parp1 genotypes. There is a highly
statistically signiﬁcant difference between the frequency of eye spots in
Parp1
/ mice compared to wild-type and heterozygous controls
(P=0.0001 using the non-parametric Kruskal-Wallis test. A Dunn’s
test determined that the null group is different from the other two).
The x-axis is expressed as whole number counts of eye spots, while the
y-axis is expressed as percent of RPE assayed for that genotype. For
example, over 80% of the Parp1
/ RPE had greater than 10 eye spots.
Table 1. Summary of RPE examined and p












+/+ 42 287 6.8 3.5
Parp1
+/ 34 264 7.8 2
Parp1
/ 28 545 19.5 6.2
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quency and positional analysis showed no difference
between wild-type and heterozygous, the data for these
two groups were combined and compared against the
null group in a 22 contingency table analysis
( 
2=28.64, P<0.0001). These results indicate that there
is a signiﬁcant increase in the incidence of large spots in
the Parp1 null mice compared to controls, indicating an
increase in HRR in proliferating cells.
To investigate whether a particular subset of spots
(single cell or multi-cell) caused the observed shift in
spots to an earlier time in development in Parp1 null
mice, a Kruskal–Wallis test was used to analyze the
relative positions of these subsets of eye spots between
genotypes. This test revealed that multi-cell eye spots are
shifted toward the optic nerve in the null mice as
compared to heterozygous and wild-type (P=0.0001).
Furthermore, analysis of the single-cell eye spots showed
no difference between groups (P=0.5762, Kruskal–
Wallis test), indicating that the positional shift observed
when analyzing all spots is in fact due to the multi-cell eye
spots. Considering that the Parp1 null mice display both
an increase in the large eye spots and the position of these
eye spots, we examined whether these large eye spots are
signiﬁcantly increased in the proximal half of the RPE in
the absence of PARP1. A 22 contingency table analysis
revealed that indeed there was a signiﬁcant increase in
large, multi-cell events (11 cells) in the proximal half of
the RPE in null mice compared to control RPE
( 
2=5.49, P=0.019, Figure 3). This suggests that
many more highly replicative cells are prone to p
un rever-
sion events during early RPE development in the absence
of PARP1.
Loss of Parp1 leads to an increase in RAD51 nuclear foci
It has been previously reported that human cells either
deﬁcient or inhibited for PARP1 have increased RAD51
nuclear foci, an indicator of increased HRR (16,17). To
demonstrate that the same cellular phenomenon is
observed here with the mouse Parp1 knockout model,
we examined spontaneous levels of RAD51 nuclear foci
in MEFs isolated from these mice (Figure 5). As expected,
the observed frequency of spontaneous RAD51 foci for
wild-type MEFs displayed a very low background, mostly
in the category of 0–5 RAD51 foci per cell. However,
Parp1 null MEFs showed a high number of cells with
RAD51 foci with 68.3% having >6 foci per cell
compared to wild-type MEFs (23.5%) (P=2.6e–29). In
addition, comparing 0 foci to either the 6–10 or >10 foci
per cell groups demonstrates a signiﬁcant increase in
numbers of foci per cell in the Parp1 null cells
(P=3.3e–15 and P=8.3e–25, respectively). This data
suggests a signiﬁcantly higher frequency of HRR in
Figure 3. Positional distribution of spots in mice with differing Parp1 genotypes. The position of an eyespot is a measurement relative to the optic
nerve head. The position ‘0’, which represents the optic nerve head, correlates to p
un reversion events that occurred relatively early in eye develop-
ment. The position ‘1’, which represents spots at the edge of the RPE, correlates to reversion events that occurred at a later time in eye development.
Non-parametric analysis with a Kruskal–Wallis test (P=0.013) followed by a Dunn’s Test indicated that there is an increase in HRR more proximal
to the optic nerve, and presumably earlier in eye development, in Parp1 null mice compared to wild-type and heterozygous controls. Wild-type and
heterozygous controls showed no difference, so data were combined in this graphical representation to compensate visually for disparity in sample
sizes between the null group and either of the controls. The position (along the x-axis) and size (along the y-axis) of each individual eye spot is
represented as a dot. The vertical marker delineates the position that is halfway between the optic nerve head and the edge of the RPE. The
horizontal marker represents the divide between large and small eye spots and is therefore at the 11-cell size marker. Any dot on or above this line
represents a ‘large’ eye spot.
7542 Nucleic Acids Research, 2010,Vol.38, No. 21Parp1 null MEFs compared to wild-type, correlating well
with our in vivo p
un assay observations.
DISCUSSION
The inhibition of PARP1 activity is an exciting novel
therapy used in the treatment of BRCA1 and BRCA2
hereditary breast and ovarian cancers (22). The mechan-
ism by which this therapy is thought to work is by syn-
thetic lethality resulting from an inability to repair SSBs
by either PARP1-dependent SSB repair or BRCA1/
2-dependent HRR (after replication fork stall/ collapse)
(4,23,24). This model would suggest an increase in the
spontaneous frequency of HRR in the absence of
PARP1. In vitro evidence for a hyper-recombination
phenotype has been presented in various tissue culture
experiments (16,17,19–21). Here, we provide in vivo
evidence that spontaneous HRR frequency is indeed
increased in the absence of PARP1 protein by using an
established mouse model for measuring HRR events.
HRR dependent repair of SSBs has been proposed to be
due to DNA replication fork collapse at the SSB that
converts these lesions into HRR substrates. Our data
supports this notion, with a signiﬁcant increase in large
clonal eye spots in the Parp1 null background compared
to controls. There is no selective advantage for p
un rever-
sion, thus it is likely that similar somatic homologous re-
combination events are occurring in replicating cells
throughout all tissues of the body and not just in the de-
veloping RPE and at the p
un locus.
The p
un HRR assay is based on the loss of one copy of a
DNA duplication that encompasses exons 6–18 of the
Figure 4. The size of eye spots in mice with differing Parp1 genotypes. Eye spot size is expressed as the number of pigmented RPE cells comprising
the eye spot (y-axis). A statistically signiﬁcant increase in the number of large eye spots in Parp1 null mice ( 
2=32.65, p<0.0001) compared to
wild-type and heterozygous controls is shown by using a 23 contingency table. Comparison of null against combined wild-type and heterozygous
data in a 22 contingency table also demonstrated a statistically signiﬁcant difference in the null group ( 
2=28.64, p<0.0001).
Figure 5. Spontaneous frequency of RAD51 nuclear foci in wild-type
and Parp1 null MEFs. (A) Frequency of RAD51 foci per cell by geno-
type categorized in 0, 1–5, 6–10 and >10 foci by Parp1 genotype
provided as a percentage of cells in the bar graph and actual
numbers of cells in the table. There is a statistically signiﬁcant
increase in cells with RAD51 foci in Parp1 null MEFs compared to
wild-type MEFs (comparing 0–5 foci per cell to >6 foci, P=2.6e–29).
Furthermore, there are more RAD51 foci present per cell in the
absence of PARP1. Representative ﬁeld of cells with RAD51 foci
positive cells are presented in (B) for wild-type and (C) for Parp1
null MEFs. Blue is DAPI and green is RAD51, taken with a 40
objective.
Nucleic Acids Research, 2010,Vol.38, No. 21 7543p gene, restoring the function of this pigmentation gene.
Theoretically the p
un reversion event, a homology directed
deletion, may be mediated by either of two alternative
mechanisms (36). First, there is the canonical, RAD51/
BRCA1-dependent HRR pathway and is likely instigated
by either a double-stranded DNA break or DNA replica-
tion fork collapse. The alternative homology-dependent
repair pathway is SSA. SSA is a RAD51-independent
pathway that can mediate intrachromosomal deletions
between homologous DNA sequences, but is unlikely to
be dependent upon the DNA replication process and is
more likely to act in response to a double-stranded
DNA break than an SSB-induced replication fork
collapse (46,47). In contrast, RAD51-dependent HRR is
considered a high ﬁdelity DNA repair pathway and is
likely a favored mechanism in replicating cells. Therefore,
RAD51-dependent HRR provides the most obvious
explanation for the observation that earlier p
un reversion
events in proliferating cells will lead to larger eye spots.
Using the p
un assay, we previously reported that there is
a signiﬁcant increase in HRR in Atm, p53 and Gadd45a
null mice compared to controls (28). While these models
showed differing shifts in the timing of events (position of
eye spots) (28), the distribution of eye spot size was
equivalent to wild-type (a majority of single cell eye
spots, fewer two cell eye spots, and so forth, Bishop,
unpublished data). In contrast, in the Parp1 null mice
we observed a signiﬁcant increase in the number of
multi-cell spots, particularly those greater than 10 cells
(Figure 4). It is possible that different HRR pathways
are at work in these different mutant mice, with a prefer-
ence for replication-tied RAD51-dependent HRR events
observed in PARP1 null mice.
It has already been postulated that the mechanism by
which Parp1 nullizygosity increases HRR is through rep-
lication fork collapse. Therefore, it is probable that it
is the RAD51/BRCA1-dependent HRR pathway that
results in the hyper-recombination phenotype we have
observed in the Parp1 null animals. In such a case, it
would logically follow that more of the spots consist of
a greater number of cells because the original cell in which
the p
un reversion occurred was a proliferating cell; the
daughter cells would have inherited the reverted p allele
and thus will also be pigmented. However, in wild-type, as
well as in Atm, p53 and Gadd45a null mice, the majority of
spots are single-cell events. These events follow the same
general pattern of positions as larger spots, but with a
phase shift toward the optic nerve. This relative distribu-
tion suggests that the single-cell events were likely to have
occurred in cells that were in their terminal division at the
rear of the proliferating region of the RPE (28). Therefore,
it is possible that these single-cell events were not neces-
sarily tied to active replication machinery, but rather
could be due to SSA, in a DNA replication-independent
manner. BRCA1-dependent HRR is thought necessarily
to involve RAD51 (48) yet SSA is thought to be a
RAD51-independent event (36). In support of this, we
observe a signiﬁcant increase in spontaneous nuclear
RAD51 foci in the absence of PARP1. Though we
cannot determine the proportion of p
un reversions that
result from SSA events, it appears that the absence of
PARP1 results in a clear increase in p
un reversion events
that are tied to cellular proliferation and DNA replication.
Overall, our observations provide formal evidence that the
absence of PARP1 protein results in a spontaneous
hyper-homologous recombination phenotype that
supports the proposed mechanisms of PARP1 inhibition
and BRCA1/2 null synthetic lethality.
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